BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Oct 24, 2012
 |  BC Extra  |  Clinical News

Fujifilm-Kyowa JV to develop biosimilar Avastin

Fujifilm Kyowa Kirin Biologics Co. Ltd. announced plans to develop a biosimilar version of cancer drug Avastin bevacizumab. Clinical trials are expected to begin in 2014. Fujifilm Kyowa launched...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >